Yes. POTS has formal diagnostic criteria, ICD-10 coding, NIH consensus statements, and substantial published research. The condition is recognized by cardiology, neurology, and autonomic specialty societies. Anyone telling you POTS is anxiety is not current with the literature.

How long does POTS last?

Variable. Adolescent POTS often improves substantially by the mid-20s. Post-viral POTS in adults is variable; some patients recover fully in 12 to 24 months, others have ongoing disease. POTS associated with hEDS or MCAS is often more chronic and requires long term management.

Can I exercise with POTS?

Yes, with the right approach. Start with recumbent exercise (recumbent bike, rowing, swimming) and progress slowly using a structured protocol like the Levine program. Upright cardio is poorly tolerated initially and can worsen symptoms. Strength training in parallel from the beginning supports venous return.

Most POTS patients have a literally low blood volume. Sodium pulls water into the vascular space and supports volume. The standard "low salt" advice that is appropriate for hypertensive patients is exactly wrong for POTS patients. Most POTS patients need 3 to 5 grams of sodium per day.

Will I have to take medication forever?

Not necessarily. Many patients are able to reduce or stop medications after a year or two of stable lifestyle management. The foundation (salt, water, compression, exercise) carries through. Medications are tools we use during specific phases or for specific symptoms.

Can children have POTS?

Yes. POTS is more common in adolescent girls than is generally recognized. The diagnostic criteria use a higher heart rate threshold (40 plus rather than 30 plus beats per minute) for ages under 19. We do not see pediatric patients in our practice; we refer to pediatric cardiology with autonomic interest.

Is POTS connected to Long COVID?

Substantially. A meaningful share of Long COVID patients meet POTS criteria. Treating the POTS component is often a key part of Long COVID recovery. Most POTS specialists agree the post-viral mechanism is the same regardless of which specific virus triggered it.

What is the connection between POTS, MCAS, and hEDS?

The three conditions cluster, possibly because of shared genetic and connective tissue factors. Many patients with one have at least subclinical features of the other two. We screen for all three when one is suspected and treat in parallel.

Can I drive with POTS?

Most POTS patients can drive safely. We recommend caution if you have had pre-syncope (near fainting) episodes, particularly if poorly controlled. Sitting with good support and air conditioning helps. Patients with documented syncope (loss of consciousness) episodes should not drive until cleared by their physician.

Can I get pregnant with POTS?

Yes. Many POTS patients have successful pregnancies. POTS symptoms often improve during pregnancy due to expanded blood volume, then worsen postpartum. We coordinate with maternal-fetal medicine for pregnancy management and adjust medications appropriately (some POTS medications are not pregnancy compatible).

Are there POTS clinics in Philadelphia?

Penn Medicine has cardiac electrophysiologists with autonomic interest. Children's Hospital of Philadelphia has a strong pediatric POTS program. For adult patients, autonomic specialty referral is sometimes needed but most management can be done in coordination with primary care.

How does Fishtown Medicine coordinate with cardiology and autonomic specialists?

For complex cases requiring tilt table testing, autonomic function testing, or specialty medication management, we refer to cardiac electrophysiology or autonomic neurology. We act as the primary care quarterback, manage day to day, and provide a stable medical home while specialists provide diagnostic testing and confirm the management plan.

What is the role of fludrocortisone in POTS?

Fludrocortisone (Florinef) is a mineralocorticoid that increases sodium retention and expands plasma volume. Doses range from 0.05 to 0.2 mg daily. We monitor potassium because fludrocortisone causes potassium loss. Side effects include weight gain and edema in some patients. It is one of the most useful medications in pure hypovolemic POTS.

How do you handle severe POTS that does not respond to standard therapy?

For refractory POTS, we consider IVIG (in autoimmune POTS), regular IV saline infusions, ivabradine in higher doses, droxidopa, or referral to autonomic specialty centers (Vanderbilt, Mayo Clinic, Cleveland Clinic). Severe POTS is disabling, and the threshold for escalating care should be low.

What is the role of small fiber neuropathy testing?

Skin biopsy for small fiber nerve density (intraepidermal nerve fiber density) can document neuropathic POTS. The result can guide decisions about IVIG and other immunomodulatory therapy. We do not routinely order this test for every POTS patient, but it is appropriate for suspected immune mediated or refractory cases.

How do you handle the MCAS overlap?

Many POTS patients have concurrent MCAS. Treating MCAS often improves POTS symptoms because mast cell mediators directly affect vascular tone and autonomic function. We screen with serum tryptase and 24 hour urine N-methylhistamine, and we treat with H1/H2 blockers and mast cell stabilizers when indicated. The two conditions interact, and treating only one often leaves residual disease.

What about hEDS overlap?

Hypermobile Ehlers-Danlos Syndrome (hEDS) is characterized by joint hypermobility, soft skin, and connective tissue laxity. The overlap with POTS appears to be due to vascular wall laxity that worsens venous pooling. We screen with the Beighton score and the 5 part questionnaire. Management includes physical therapy with hEDS expertise, joint protection, and treatment of POTS in parallel.

How does Fishtown Medicine handle the disability and accommodation needs of POTS patients?

We provide documentation for school and workplace accommodations: extra breaks, access to water and salt, ability to sit or recline, modified physical education, and remote work options when needed. We support disability applications for severely affected patients. We work with vocational rehabilitation when partial return to work becomes possible.

What is the prognosis for POTS?

Variable. With appropriate treatment, most POTS patients achieve substantial functional improvement. Adolescent onset POTS often improves substantially by the mid-20s. Post-viral POTS in adults is variable; some recover fully, others have ongoing disease. Secondary POTS (with hEDS, MCAS) is often chronic but manageable.

What is the Warm Invitation Call?

It is a 20 minute video conversation, free, with no commitment. You tell us your story, what testing has been done, and what is and is not working. We tell you whether the model fits. If we are not a good fit for your specific complexity, we will say so and often help you find a better option.

Yes. POTS has formal diagnostic criteria, ICD-10 coding, NIH consensus statements, and substantial published research. The condition is recognized by cardiology, neurology, and autonomic specialty societies. Anyone telling you POTS is anxiety is not current with the literature.

How long does POTS last?

Variable. Adolescent POTS often improves substantially by the mid-20s. Post-viral POTS in adults is variable; some patients recover fully in 12 to 24 months, others have ongoing disease. POTS associated with hEDS or MCAS is often more chronic and requires long term management.

Can I exercise with POTS?

Yes, with the right approach. Start with recumbent exercise (recumbent bike, rowing, swimming) and progress slowly using a structured protocol like the Levine program. Upright cardio is poorly tolerated initially and can worsen symptoms. Strength training in parallel from the beginning supports venous return.

Most POTS patients have a literally low blood volume. Sodium pulls water into the vascular space and supports volume. The standard "low salt" advice that is appropriate for hypertensive patients is exactly wrong for POTS patients. Most POTS patients need 3 to 5 grams of sodium per day.

Will I have to take medication forever?

Not necessarily. Many patients are able to reduce or stop medications after a year or two of stable lifestyle management. The foundation (salt, water, compression, exercise) carries through. Medications are tools we use during specific phases or for specific symptoms.

Can children have POTS?

Yes. POTS is more common in adolescent girls than is generally recognized. The diagnostic criteria use a higher heart rate threshold (40 plus rather than 30 plus beats per minute) for ages under 19. We do not see pediatric patients in our practice; we refer to pediatric cardiology with autonomic interest.

Is POTS connected to Long COVID?

Substantially. A meaningful share of Long COVID patients meet POTS criteria. Treating the POTS component is often a key part of Long COVID recovery. Most POTS specialists agree the post-viral mechanism is the same regardless of which specific virus triggered it.

What is the connection between POTS, MCAS, and hEDS?

The three conditions cluster, possibly because of shared genetic and connective tissue factors. Many patients with one have at least subclinical features of the other two. We screen for all three when one is suspected and treat in parallel.

Can I drive with POTS?

Most POTS patients can drive safely. We recommend caution if you have had pre-syncope (near fainting) episodes, particularly if poorly controlled. Sitting with good support and air conditioning helps. Patients with documented syncope (loss of consciousness) episodes should not drive until cleared by their physician.

Can I get pregnant with POTS?

Yes. Many POTS patients have successful pregnancies. POTS symptoms often improve during pregnancy due to expanded blood volume, then worsen postpartum. We coordinate with maternal-fetal medicine for pregnancy management and adjust medications appropriately (some POTS medications are not pregnancy compatible).

Are there POTS clinics in Philadelphia?

Penn Medicine has cardiac electrophysiologists with autonomic interest. Children's Hospital of Philadelphia has a strong pediatric POTS program. For adult patients, autonomic specialty referral is sometimes needed but most management can be done in coordination with primary care.

How does Fishtown Medicine coordinate with cardiology and autonomic specialists?

For complex cases requiring tilt table testing, autonomic function testing, or specialty medication management, we refer to cardiac electrophysiology or autonomic neurology. We act as the primary care quarterback, manage day to day, and provide a stable medical home while specialists provide diagnostic testing and confirm the management plan.

What is the role of fludrocortisone in POTS?

Fludrocortisone (Florinef) is a mineralocorticoid that increases sodium retention and expands plasma volume. Doses range from 0.05 to 0.2 mg daily. We monitor potassium because fludrocortisone causes potassium loss. Side effects include weight gain and edema in some patients. It is one of the most useful medications in pure hypovolemic POTS.

How do you handle severe POTS that does not respond to standard therapy?

For refractory POTS, we consider IVIG (in autoimmune POTS), regular IV saline infusions, ivabradine in higher doses, droxidopa, or referral to autonomic specialty centers (Vanderbilt, Mayo Clinic, Cleveland Clinic). Severe POTS is disabling, and the threshold for escalating care should be low.

What is the role of small fiber neuropathy testing?

Skin biopsy for small fiber nerve density (intraepidermal nerve fiber density) can document neuropathic POTS. The result can guide decisions about IVIG and other immunomodulatory therapy. We do not routinely order this test for every POTS patient, but it is appropriate for suspected immune mediated or refractory cases.

How do you handle the MCAS overlap?

Many POTS patients have concurrent MCAS. Treating MCAS often improves POTS symptoms because mast cell mediators directly affect vascular tone and autonomic function. We screen with serum tryptase and 24 hour urine N-methylhistamine, and we treat with H1/H2 blockers and mast cell stabilizers when indicated. The two conditions interact, and treating only one often leaves residual disease.

What about hEDS overlap?

Hypermobile Ehlers-Danlos Syndrome (hEDS) is characterized by joint hypermobility, soft skin, and connective tissue laxity. The overlap with POTS appears to be due to vascular wall laxity that worsens venous pooling. We screen with the Beighton score and the 5 part questionnaire. Management includes physical therapy with hEDS expertise, joint protection, and treatment of POTS in parallel.

How does Fishtown Medicine handle the disability and accommodation needs of POTS patients?

We provide documentation for school and workplace accommodations: extra breaks, access to water and salt, ability to sit or recline, modified physical education, and remote work options when needed. We support disability applications for severely affected patients. We work with vocational rehabilitation when partial return to work becomes possible.

What is the prognosis for POTS?

Variable. With appropriate treatment, most POTS patients achieve substantial functional improvement. Adolescent onset POTS often improves substantially by the mid-20s. Post-viral POTS in adults is variable; some recover fully, others have ongoing disease. Secondary POTS (with hEDS, MCAS) is often chronic but manageable.

What is the Warm Invitation Call?

It is a 20 minute video conversation, free, with no commitment. You tell us your story, what testing has been done, and what is and is not working. We tell you whether the model fits. If we are not a good fit for your specific complexity, we will say so and often help you find a better option.

The POTS & Dysautonomia Strategy

TL;DR30-second take

Postural Orthostatic Tachycardia Syndrome (POTS) is a form of autonomic dysfunction where heart rate rises 30+ beats per minute on standing without a drop in blood pressure. The POTS Strategy covers diagnosis (10 minute lean test, tilt table), volume expansion (3 to 5 grams sodium, 3 liters water), compression, recumbent exercise progression, and medications when needed (beta blockers, ivabradine, midodrine, fludrocortisone).

Read Time: 18 Minutes
Clinical Focus: Orthostatic Intolerance, Blood Volume, Vagus Nerve

You stand up and your heart rate goes from 70 to 120. You feel dizzy, shaky, and anxious. You crave salt like a deer at a salt lick. You hate the heat. You have been told you have anxiety, you should drink more coffee in the morning, or you just need to exercise more.

This is Postural Orthostatic Tachycardia Syndrome (POTS). Your autonomic nervous system, the software that controls blood pressure, heart rate, digestion, and temperature, is failing to fight gravity. The POTS Strategy is the playbook we use to stabilize the system: volume expansion, compression, recumbent exercise progression, and medication when needed.

What is happening in POTS?

POTS is defined by a sustained heart rate increase of 30 beats per minute or more (40 or more in adolescents) within 10 minutes of standing, without a meaningful drop in blood pressure, accompanied by symptoms of orthostatic intolerance. Several mechanisms can produce this pattern.

1. Hypovolemia (Low Blood Volume)

Many POTS patients have a literally lower blood volume than healthy controls. Standing causes blood to pool in the lower extremities and abdomen, and there is not enough volume left to maintain cerebral perfusion. The body compensates by increasing heart rate.

2. Neuropathic POTS

Small fiber neuropathy in the lower extremities prevents the vasoconstriction that normally pushes blood back to the heart on standing. Often associated with autoimmune drivers, post-viral injury, or diabetes.

3. Hyperadrenergic POTS

The body releases excess norepinephrine on standing as a compensation, driving heart rate well above what is needed. Standing norepinephrine levels above 600 pg/mL support this subtype.

4. Secondary POTS

POTS can develop after viral illness (Long COVID, EBV), in connective tissue disorders (hypermobile Ehlers-Danlos), in mast cell activation syndrome, after pregnancy, or alongside other autoimmune conditions.

What does the diagnostic workup look like?

Bedside Diagnostic Tests

10 minute lean test (active stand): Measure heart rate and blood pressure supine after 5 to 10 minutes of rest, then at 1, 3, 5, and 10 minutes of standing. Sustained heart rate increase of 30 plus (40 plus in adolescents under 19) without significant blood pressure drop and with symptoms confirms diagnosis.
Tilt table test: More controlled and reproducible. Done in cardiology or autonomic specialty clinic.

Supportive Workup

ECG and Holter: To document sustained tachycardia and rule out other cardiac causes.
Echocardiogram: To rule out structural heart disease.
Standing norepinephrine: Helps subtype hyperadrenergic POTS.
Autonomic function testing: Sweat testing (QSART), skin biopsy for small fiber density, cardiac vagal testing, in specialty centers.
Comorbidity screening: hEDS (Beighton score), MCAS (tryptase, urine N-methylhistamine), thyroid, ferritin, vitamin D, B12.

What is the strategic roadmap for POTS treatment?

Phase 1: Volume Expansion (Foundation)

Volume expansion is the single most important intervention. Most patients will not respond to anything else without this in place.

Sodium: 3,000 to 5,000 mg per day, in food and electrolyte mixes. (Standard low salt advice is wrong for POTS patients.)
Water: 2.5 to 3 liters per day minimum.
Electrolyte mixes: LMNT (1 gram sodium per packet), Vitassium salt sticks (250 mg per stick), Liquid I.V., or homemade sodium chloride solutions.
Salt loading at strategic times: 16 oz water with 1 gram sodium upon waking, before exercise, and before any prolonged standing.

Phase 2: Mechanical Compression

External compression supports venous return and reduces blood pooling.

Abdominal binder: More effective than socks alone. Compresses the splanchnic (gut) blood pool, which is the largest reservoir of blood pooling.
Compression tights: Waist-high, 20 to 30 mmHg. Knee-high stockings are inadequate for POTS because they leave the largest pooling areas uncompressed.
Strategic use: Wear compression during periods of standing, exercise, and travel. Remove at night.

Phase 3: Recumbent Exercise Progression (The Levine Protocol)

Fishtown Medicine

A 90-minute conversation with Dr. Ash. A written plan you can actually follow.

Start your intake

Inactivity and deconditioning worsen POTS. The Dr. Benjamin Levine protocol, developed at Texas Health Presbyterian, is a structured 8 month exercise progression that consistently improves POTS in clinical trials.

Phase 1 (Months 1-3): Recumbent exercise only. Recumbent bike, rowing machine, swimming. Avoid upright cardio.
Phase 2 (Months 4-6): Add semi-recumbent exercise. Stationary bike with seat back, elliptical with arms.
Phase 3 (Months 7-8): Gradual upright exercise. Treadmill walking, then upright cycling.
Strength training: Lower body resistance training in parallel from the start. Improves muscle pump function and venous return.
Heart rate ceilings: We use age-appropriate target zones, modified for POTS to avoid pushing into the high-symptom range.

Phase 4: Medications (When Needed)

Many patients need medication in addition to lifestyle. We layer based on symptom pattern.

Beta blockers (low dose): Propranolol 10 to 20 mg twice daily, or metoprolol 12.5 to 25 mg twice daily. Reduces tachycardia. Often poorly tolerated in patients with low blood pressure.
Ivabradine: 2.5 to 7.5 mg twice daily. Slows heart rate without affecting blood pressure. Often the better tolerated option for low blood pressure POTS.
Midodrine: 2.5 to 10 mg three times daily. Vasoconstrictor that raises blood pressure on standing. Take while upright; do not take within 4 hours of bedtime.
Fludrocortisone: 0.05 to 0.2 mg daily. Mineralocorticoid that expands blood volume. Monitor potassium.
Pyridostigmine: 30 to 60 mg three times daily. Acetylcholinesterase inhibitor that improves vagal tone. Useful in some hyperadrenergic patients.
IV saline (rescue): 1 to 2 liters during severe flares. Some patients with severe disease use scheduled weekly infusions.

Phase 5: Treating the Drivers

POTS often has underlying contributors that need separate attention.

Mast cell activation: H1/H2 blockers, mast cell stabilizers if MCAS is present.
Autoimmune drivers: Workup for autonomic ganglionic antibodies and other immune markers in select patients.
Long COVID: Treat the post-viral state in parallel; many POTS patients have a clear post-viral onset.
hEDS: Physical therapy with PT trained in connective tissue disorders.

Actionable Steps for Suspected POTS

Do a home lean test: Lie flat for 10 minutes, measure heart rate. Stand. Measure heart rate at 1, 3, 5, and 10 minutes. Note your symptoms. A sustained increase of 30 plus beats per minute is suggestive.
Start salt and water now: 3 grams of sodium and 2.5 liters of water per day. LMNT or homemade electrolyte mix.
Get compression: Abdominal binder plus waist high compression tights, 20 to 30 mmHg.
Stop upright cardio: Switch to recumbent bike or rowing until you have a treatment plan.
Find a physician who knows POTS: Many cardiologists are not POTS-specialists. The clinical knowledge is concentrated in autonomic specialists, cardiac electrophysiology with autonomic interest, and certain primary care practices.

Scientific References

Vernino, S., et al. (2021). Postural tachycardia syndrome (POTS): State of the science and clinical care from a 2019 NIH Expert Consensus Meeting. Autonomic Neuroscience, 235, 102828.
Fu, Q., et al. (2010). Cardiac origins of the postural orthostatic tachycardia syndrome. Journal of the American College of Cardiology, 55(25), 2858-2868.
Sheldon, R. S., et al. (2015). 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm, 12(6), e41-e63.
Bryarly, M., et al. (2019). Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar. Journal of the American College of Cardiology, 73(10), 1207-1228.
Goldstein, D. S., et al. (2019). Sympathoadrenal imbalance and postural tachycardia. Autonomic Neuroscience, 215, 78-87.

Conclusion

Gravity is your enemy right now. We turn it back into your friend.

Book Your Diagnostic. Let's get you standing.

Fishtown Medicine | Playbooks

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Book Your Diagnostic

Frequently Asked Questions

Common Questions

POTS produces a heart rate increase that is reproducible on standing and improves with lying down or applying compression. Anxiety produces tachycardia that often correlates with thought content, persists in any position, and does not respond to volume expansion or compression. Many POTS patients have been incorrectly diagnosed with anxiety because both conditions cause palpitations and lightheadedness.

Deep-Dive Questions

We subtype POTS first. Hypovolemic POTS responds best to intensive volume expansion and fludrocortisone. Neuropathic POTS often responds to midodrine and pyridostigmine. Hyperadrenergic POTS responds best to ivabradine, beta blockers, and clonidine in select cases. Secondary POTS (Long COVID, MCAS, hEDS) requires treating the underlying driver in parallel. The personalization is in the subtype-driven medication selection.

The Levine protocol is a structured 8 month exercise rehabilitation program developed at Texas Health Presbyterian that consistently improves POTS in clinical trials. The program starts with recumbent exercise to avoid the orthostatic stress of upright cardio while building cardiovascular conditioning, then progresses to semi-recumbent and finally upright exercise. Strength training runs in parallel from the start. The mechanism is improved cardiac fitness, larger left ventricular cavity size with stroke volume gains, and improved venous return through muscle pump function.

Ready when you are

Start your intake

Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.

TL;DR30-second take

Read Time: 18 Minutes
Clinical Focus: Orthostatic Intolerance, Blood Volume, Vagus Nerve